<DOC>
	<DOCNO>NCT01472055</DOCNO>
	<brief_summary>The purpose study analysis pharmacokinetics fludarabine hematopoietic stem cell transplantation pediatric patient .</brief_summary>
	<brief_title>Pharmacokinetic Study Fludarabine Pediatric Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>Fludarabine commonly use chemotherapeutic agent hematopoietic stem cell transplantation child . However , pharmacokinetic study thus far conducted pediatric patient . Fludarabine cause adverse reaction include neurotoxicity , damage lung . Pharmacokinetic study critical predict safety fludarabine pediatric patient . Through individualize pharmacokinetic study ( entail numerous sampling ) fludarabine pediatric patient , study aim develop sampling-minimized analysis method study population pharmacokinetics . Through pharmacokinetic analysis , aim evaluate whether pediatric patient show similar population pharmacokinetics adult , fludarabine authorize , evaluate safety ( toxicity ) efficacy ( event free survival ) .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>1 . Conditioning regimen include fludarabine 2 . Age : &lt; 19 year old 3 . Functional class : ECOG 02 4 . No loss function major organ . Criteria may individualize . Heart : shorten fraction &gt; 30 % , ejection fraction &gt; 45 % . Liver : total bilirubin &lt; 2 ⅹ upper limit normal ; ALT &lt; 3 ⅹ upper limit normal . Kidney : creatinine &lt; 2 ⅹ normal creatinine clearance ( GFR ) &gt; 60 ml/min/1.73m2 . 5 . No active viral fungal infection 6 . Appropriate hematopoietic stem cell donor 7 . Informed consent patient ' parent 1 . Pregnant breast feed 2 . Disease progression due clinical test 3 . Psychiatric disease may interfere clinical test 4 . Whether attend physician consider patient inappropriate study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Hematopoietic stem cell transplantation fludarabine base conditioning</keyword>
</DOC>